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Abstract
Hepatoid carcinoma (HC) is an extremely rare form of neoplasm. Its cellular structure resembles that of a
hepatocellular carcinoma (HCC). To date, only 26 cases of hepatoid carcinoma of the pancreas have been reported
in the literature. We report the diagnosis of a hepatoid carcinoma of the pancreatic head in a 78-year-old male
patient. The tumor was detected incidentally during routine abdominal ultrasound scanning. Laboratory tests did
not show any abnormalities except for a monoclonal gammopathy of undetermined significance. After CT,
MRI, and laparoscopic biopsy that failed to obtain the diagnosis, the patient underwent a Whipple procedure.
The final pathology report described a hepatoid carcinoma of the pancreatic head (pathological T3, N0 (0/10),
L0, V0, R0, M0). After the patient recovered, no further therapy was recommended by the tumor board and
he was discharged. Regular follow-up was suggested; however, the patient suddenly died of acute coronary
artery disease 2 months after surgery.
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Background
Hepatoid carcinoma is an extremely rare form of neo-
plasm. Its cellular structure resembles that of a hepato-
cellular carcinoma (HCC). Hepatoid carcinoma (HC)
has been described in various organs and systems such
as the gastrointestinal tract, testes, ovaries, and lungs
[1]. We present a case of a HC of the pancreatic head in
a 78-year-old male patient.
Case presentation
A 78-year-old male patient with diabetes underwent an
annual abdominal ultrasound scan. He had no com-
plaints, and his diabetes was controlled well. The patient
denied experiencing weight loss, nausea, jaundice, fever,
and other diseases. He was a non-smoker without in-
creased alcohol consumption.
Physical examination showed a soft, non-tender, and
non-distended abdomen with no masses and normal
bowel sounds. Contrast-enhanced ultrasound revealed
an 8 × 6 cm large, hypervasculated tumor in segment I
of the liver with infiltration in the pancreas. An MRI
showed an 8-cm large, hypointense mass with a prob-
able hepatic origin and abnormal growth retroperiton-
eal to the pancreatic head (Fig. 1a, b). The large
vessels seemed to be compressed but not infiltrated.
Laboratory studies revealed a monoclonal gammopa-
thy of undetermined significance (MGUS) with urine
protein excretion at 69 mg/g creatinine. The tumor
markers AFP, CA 19-9, and CEA were not elevated.
Abdominal and thoracic CT-scans with contrast en-
hancement confirmed the 8-cm large mass between
the pancreatic head and an additional hemangioma
(Fig. 2a, b) in segment 8. There was no evidence of
metastases.
It was assumed that the monoclonal IgA gammopa-
thy was not associated with the current disease. To de-
termine the nature of the retroperitoneal mass, a CT-
guided biopsy was performed forwarding only fibrous
cells. An exploratory laparoscopy was done next, and a
laparoscopic ultrasound showed a homogenous mass
behind the pancreatic head separated from the liver.
The mesentery root was not infiltrated. Core needle
biopsies showed “epithelial tumor of an unknown
dignity”; further classification was not possible. As a
malignant tumor was still strongly suspected, the patient
underwent surgical resection (Whipple procedure) and
* Correspondence: donikastamatova88@abv.bg
1HELIOS Hospital Pforzheim, Kanzlerstrasse 2 – 7, Pforzheim 75175, Germany
2Department of Surgery, HELIOS Hospital Pforzheim, Kanzlerstrasse 2 – 7,
Pforzheim 75175, Germany
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made.
Stamatova et al. Surgical Case Reports  (2016) 2:78 
DOI 10.1186/s40792-016-0197-7
the tumor was removed completely. The further clin-
ical course was uneventful. The final pathology report
described hepatoid carcinoma of the pancreatic head
with a size of 12 cm without infiltration of the duo-
denal wall (pathological T3, N0 (0/10), L0, V0, R0,
stage IIB) (Fig. 3). The excised specimen displayed an
encapsulated, lobulated, well-differentiated epithelial
tumor with tumor cells growing in a solid pattern,
characterized by a large amount of cytoplasm, en-
larged round nuclei and nucleoli. Imunnohistochem-
ical staining of the tumor for hepatocyte specific
antigen (Hep Par 1) showed a strongly positive reac-
tion in the cytoplasm of the neoplastic cells while the
centrally located nuclei remained negative. Tumor
blood was supplied by a well-developed intercellular
capillary network, identified by a positive CD34 reac-
tion (Fig. 4a, b).
The postoperative recovery was slow due to gastric
atony, which required parenteral nutrition, and a ten-
dency to hypoglycemia.
Considering the age and clinical condition of the pa-
tient together with the stage of the disease, no further
therapy was recommended by the tumor board and he
was discharged home. Regular follow-up was to take
place. Two months after surgery, the patient suddenly
suffered an acute heart attack and was pronounced dead
upon arrival at the emergency room.
Discussion
Hepatoid carcinoma is an extremely rare form of neo-
plasm. The tumor has been found in various organs,
including the gastrointestinal tract, testes, and ovaries
[2–5]. Recently, Motooka and colleagues reported a new
case of a hepatoid carcinoma of the lung [6]. The diag-
nosis is complex, since the tumor can clinically mimic
other neoplasms and the laboratory results are often un-
specific as in this reported case. Discriminating from a
Fig. 1 MRI scan of the discovered mass which compresses the large
intraabdominal vessels (arrow)1a transverse section of the tumor 1b
frontal section
Fig. 2 CT scan showing a large hypodense mass between the liver
and the pancreas head (2a and 2b)
Stamatova et al. Surgical Case Reports  (2016) 2:78 Page 2 of 5
HCC and neuroendocrine tumors using medical imaging
is challenging. A CT- or an endoscopy-guided fine nee-
dle biopsy should be performed when possible.
The cellular structure of the tumor resembles that of a
HCC. Typical histological features are islands of large
tumor cells growing in a trabecular or perisinusoidal
pattern, displaying an eosinophilic cytoplasm and round
nuclei as well as prominent nucleoli [1, 7, 8]. It is as-
sumed that HC derives from ectopic liver tissue because
both the pancreas and liver have a common embryologic
origin—the foregut endoderm [7]. Some tumor cells ex-
press AFP, hepatocyte antigen, and cytokeratin. AFP [9]
and PIVKA-II [10] have been suggested as a tumor
marker for the disease. Staining for hepatocellular differ-
entiation is typically positive, including hepatocyte paraf-
fin 1 (HepPar1), polyclonal CEA (canalicular), and CD10
(canalicular). The differential diagnosis of hepatoid
carcinoma includes acinar cell carcinoma and pancreato-
blastoma, both can express AFP, as well asintraductalon-
cocytic papillary neoplasm, which consistently stains for
HepPar1, but it does not possess true hepatocellular dif-
ferentiation [11]. In order to exclude a metastatic HCC,
some authors suggest the examination of two specific
hepatocyte-transporters (bile salt export pump (BSEP)
and multidrug-resistance protein 3 (MDR3)) which are
not usually expressed by HC tumor cells [12].
To date, only 26 cases of pancreatic HC have been re-
ported in the literature. The patients’ age ranged from
21 to 80 years. Most of them were male (16M/10F).
Thirteen patients were either asymptomatic or suffered
from unspecific abdominal pain. Four patients however
showed jaundice. All patients underwent surgery and/or
chemotherapy. Nine of them died despite therapy within
2 to 101 months after diagnosis. In 7 cases, extensive
hepatic metastases were noticed. There are reports
which describe the tumor as highly aggressive with a
tendency for early hepatic metastases [13]. Most authors
report pure HC [14–16]. These tumors have the highest
incidence of metastasis and the worst prognosis. In some
cases, the tumor has been found associated with a neu-
roendocrine carcinoma [9, 17, 18]. The latter showed a
longer survival and sensitivity to radiochemotherapy [9].
Three of the cases describe tumors with primarily hepa-
tocellular differentiation [19–21], and the authors sus-
pect the origin of the tumors to be ectopic liver tissue.
In those cases, the tumors were not metastatic and the
patients had improved survival. Association of HC [7],
with a serous microcystic cystadenoma, has been re-
ported in a single patient who remained free from me-
tastases and showed no recurrence during the 8 months
of follow-up. One case of Papilla vateri HC was also re-
ported [22].
No standard therapy has been established due to
the tumor rarity and the lack of evidence-based data.
Tumor resection is, if possible, always recommended.
Neoadjuvant and adjuvant chemotherapy can be con-
sidered; however, standard therapy usually used for
pancreas neoplasm with gemcitabine is inefficient.
Fig. 3 Macroscopy: a well-encapsulated tumor in the head of the pancreas. There is no infiltration into the duodenum
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The XELOX protocol with oxaliplatin and capecita-
bine led to remission in some cases [7]. A short-term
regression can be achieved with sorafenib [13, 15].
Unfortunately, the long-term outcome of the current
therapy is poor. Further studies and new treatment
approaches are needed to determine the biological be-
havior of the tumor and its sensitivity to chemothera-
peutical agents.
Conclusions
We have presented a case of a non-metastatic HC of
the pancreatic head. HC is an extremely rare form of
neoplasm, which has morphological and immunohis-
tochemical features similar to those of HCC. The pa-
tient was only treated operatively, owing to his
clinical condition and considering the stage of the
tumor. He died of a sudden coronary event 2 months
after the operation.
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